Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults |
| |
Authors: | Annelie Plentz Wolfgang Jilg Tino F. Schwarz Hans B. Kuhr Olaf Zent |
| |
Affiliation: | 1. University of Regensburg, Germany;2. Stiftung Juliusspital, Würzburg, Germany;3. Practice, Regensburg, Germany;4. Novartis Vaccines, Global Medical Affairs, Emil-von-Behring-Str. 76, Marburg, Germany |
| |
Abstract: | Tick-borne encephalitis (TBE) is a potentially serious disease, especially in adults. There is no treatment available for TBE; supportive therapy may help to ease symptoms of the disease. Vaccination is the most effective method of preventing TBE disease and is recommended for those who live, work, or travel in TBE-endemic areas. Regular booster vaccinations are recommended every 3–5 years to maintain protection. Evidence from recent clinical studies suggests that TBE antibodies persist at high levels for longer than the current recommended intervals for TBE booster vaccination. |
| |
Keywords: | Tick-borne encephalitis Immunogenicity Vaccine Booster |
本文献已被 ScienceDirect 等数据库收录! |
|